Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients?: A nationwide Danish study

Carsten Lindberg Fagö-Olsen; Bent Ottesen; Henrik Kehlet; Sofie L Antonsen; Ib J Christensen; Algirdas Markauskas; Berit J Mosgaard; Christian Ottosen; Charlotte H Soegaard; Erik Soegaard-Andersen; Claus Hoegdall

doi:10.1016/j.ygyno.2013.11.035

Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study

Carsten Lindberg Fagö-Olsen, Bent Ottesen, Henrik Kehlet, Sofie L Antonsen, Ib J Christensen, Algirdas Markauskas, Berit J Mosgaard, Christian Ottosen, Charlotte H Soegaard, Erik Soegaard-Andersen, Claus Hoegdall

55 Citationer (Scopus)

Abstract

In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT) has increased, and the use of NACT varies among center hospitals. We aimed to evaluate the impact of first-line treatment on surgical outcome and median overall survival (MOS).

Originalsprog	Engelsk
Tidsskrift	Gynecologic Oncology
Vol/bind	132
Udgave nummer	2
Sider (fra-til)	292-298
Antal sider	7
ISSN	0090-8258
DOI	https://doi.org/10.1016/j.ygyno.2013.11.035
Status	Udgivet - 2014

Adgang til dokumentet

10.1016/j.ygyno.2013.11.035

Citationsformater

Fagö-Olsen, C. L., Ottesen, B., Kehlet, H., Antonsen, S. L., Christensen, I. J., Markauskas, A., Mosgaard, B. J., Ottosen, C., Soegaard, C. H., Soegaard-Andersen, E., & Hoegdall, C. (2014). Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study. Gynecologic Oncology, 132(2), 292-298. https://doi.org/10.1016/j.ygyno.2013.11.035

Fagö-Olsen, CL, Ottesen, B, Kehlet, H , Antonsen, SL , Christensen, IJ, Markauskas, A, Mosgaard, BJ, Ottosen, C, Soegaard, CH, Soegaard-Andersen, E & Hoegdall, C 2014, 'Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study', Gynecologic Oncology, bind 132, nr. 2, s. 292-298. https://doi.org/10.1016/j.ygyno.2013.11.035

@article{68649059a1a540c9839610406ab64b9e,

title = "Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients?: A nationwide Danish study",

abstract = "In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT) has increased, and the use of NACT varies among center hospitals. We aimed to evaluate the impact of first-line treatment on surgical outcome and median overall survival (MOS).",

author = "Fag{\"o}-Olsen, {Carsten Lindberg} and Bent Ottesen and Henrik Kehlet and Antonsen, {Sofie L} and Christensen, {Ib J} and Algirdas Markauskas and Mosgaard, {Berit J} and Christian Ottosen and Soegaard, {Charlotte H} and Erik Soegaard-Andersen and Claus Hoegdall",

note = "Copyright {\textcopyright} 2013. Published by Elsevier Inc.",

year = "2014",

doi = "10.1016/j.ygyno.2013.11.035",

language = "English",

volume = "132",

pages = "292--298",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press",

number = "2",

}

TY - JOUR

T1 - Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients?

T2 - A nationwide Danish study

AU - Fagö-Olsen, Carsten Lindberg

AU - Ottesen, Bent

AU - Kehlet, Henrik

AU - Antonsen, Sofie L

AU - Christensen, Ib J

AU - Markauskas, Algirdas

AU - Mosgaard, Berit J

AU - Ottosen, Christian

AU - Soegaard, Charlotte H

AU - Soegaard-Andersen, Erik

AU - Hoegdall, Claus

PY - 2014

Y1 - 2014

N2 - In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT) has increased, and the use of NACT varies among center hospitals. We aimed to evaluate the impact of first-line treatment on surgical outcome and median overall survival (MOS).

AB - In Denmark, the proportion of women with ovarian cancer treated with neoadjuvant chemotherapy (NACT) has increased, and the use of NACT varies among center hospitals. We aimed to evaluate the impact of first-line treatment on surgical outcome and median overall survival (MOS).

U2 - 10.1016/j.ygyno.2013.11.035

DO - 10.1016/j.ygyno.2013.11.035

M3 - Journal article

C2 - 24321400

SN - 0090-8258

VL - 132

SP - 292

EP - 298

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -

Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater